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Abstract
Purpose: The aim of this study was to evaluate the effects of Vernonia cinerea Less. (VC) supplementation and exercise 
on oxidative stress biomarkers, beta-endorphin release, and the rate of cigarette smoking.
Methods: Volunteer smokers were randomly divided into four groups: group 1: VC supplement; group 2: exercise with 
VC supplement; group 3: exercise; and group 4: control. VC was prepared by wash and dry techniques and taken orally 
before smoking, matching the frequency of strenuous exercise (three times weekly). Before and after a two month 
period, exhaled carbon monoxide (CO), blood oxidative stress (malondialdehyde [MDA], nitric oxide [NOx], protein 
hydroperoxide [PrOOH] and total antioxidant capacity [TAC]), beta-endorphin and smoking rate were measured, and 
statistically analyzed.
Results: In Group 1, MDA, PrOOH, and NOx significantly decreased, whereas TAC increased (p < 0.05). In Group 2, MDA 
and PrOOH decreased (p < 0.05), with no other changes noted (p > 0.05). In Group 3, MDA, PrOOH, NOx, TAC, and beta-
endorphin levels increased significantly (p < 0.05). Group 4 showed no change in oxidative stress variables or beta-
endorphine levels (p > 0.05). All groups had lower levels of CO after the intervention. The smoking rate for light 
cigarette decreased in group 2(62.7%), 1(59.52%), 3 (53.57%) and 4(14.04%), whereas in self-rolled cigarettes it 
decreased in group 1 (54.47%), 3 (42.30%), 2 (40%) and 4 (9.2%).
Conclusion: Supplementation with Vernonia cinerea Less and exercise provided benefit related to reduced smoking 
rate, which may be related to oxidaive stress and beta-endorphine levels.
Background
Although cigarette smoking decreased in Thailand
between 1991 and 2007 from 12.2 million to 10.86 million
smokers, it has increased among younger men (aged
approx. 18 years) and women (aged approx. 22 years).
Moreover, in low education, urban and eastern parts of
the country, cigarette smoking has increased from 9.66 to
10.26 cigarettes per smoker per day [1]. Light and self-
rolling cigarettes are generally used everywhere, espe-
cially in northern regions such as Chiang Mai province.
Cigarette smoke contains an abundance of free radicals
and prooxidant species known to negatively influence
human health [2]. Increased production of free radicals
from tobacco is recognized because of the more than
4,000 chemical substances found in tobacco [3]. Previous
reports have noted that the levels of protein carbonyl [4]
and the lipid peroxidation product malondialdehyde [5,6]
are higher in smokers than non-smokers. Therefore, ciga-
rette smoking related ill-health and disease may be mech-
anistically linked to increased production of free radicals.
Aside from monitoring bloodborne biomarkers of oxi-
dized molecules, evaluation of oxidative stress from
smoking can be determined from exhaled hydrogen per-
oxide (H2O2) or carbon monoxide (CO). Nicotine in
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smoke is known to release neuroendocrine substances,
such as beta-endorphin (β-end) [7], found in women
smokers with either high doses of nicotine cigarettes or
with heavy smoking [8,9]. Moreover, a previous report
showed that nicotine stimulates the pituitary release of
the pro-opiomelanocortin (POMC) which contains the
precursor for β-end [10].
Smoking cessation has been promoted in Thailand as
well as in other countries in the world. Previous evidence
shows that behavioral counseling and/or pharmacother-
apy is successful in long-term abstinence at a rate of
approximately 30% [11,12], and pharmacotherapy is
widely used in within the smoking clinic. Major disadvan-
tages of this approach are high cost and the unwanted
side effects such as nausea, dry mouth, weight gain, and
sedation [13].
Exercise is a popular activity that is recognized to
change in behavior and habit, including smoking cessa-
tion [14]. Acute and strenuous intensity exercise tran-
siently increases the production of free radicals or
reactive oxygen species (ROS), ultimately leading to the
activation and upregulation of antioxidant enzymes fol-
lowing various aerobic exercise protocols [15-19]. While
this increase in antioxidant defense may prove helpful in
combating smoke-induce free radical producton, perhaps
more importantly vigorous exercise may aid in smoking
abstinenice [20]. Although moderate intensity exercise
has been shown to provide both psychological benefits
and improved adherence rates [20,21], heavy intensity
exercise promotes reduction of tobacco withdrawal
symptoms and urges to smoke [22]. Lastly, exercise has
been reported to release β-end [23], especially in non-
trained volunteers using strenuous exercise [24].
Vernonia cinerea Less. (VC) is classified in the Aster-
aceae Family as a slender stemmed plant, variable in leaf
shape with pinkish-purple flowers. It has been docu-
mented and recommended in Thai traditional medicine,
as in other countries, for smoking cessation, and relief of
asthma, cough, fever, malaria, urinary calculi, and arthri-
tis. Unfortunately, little scientific data are available in
regards to these effects. VC is a perennial herbaceous
plant and distributed in grassy areas found in Southeast
Asia and Hawaii [25-27]. In a mouse model, study of the
active compound in VC had noted anti-inflammatory,
analgesic, and antipyretic activities [28]. In addition, a
methanol extract of VC has been shown to exhibit signifi-
cant anti-inflammatory activity in a rat model [29]. The
active compound is proposed as a flavonoid and terpe-
noid [30], exhibiting both anti-oxidant and anti-inflam-
matory activities.
Unsing an in vivo study, an extract from the VC flower
demonstrated an anti-oxidant effect in arthritis-induced
rats by reducing lipid peroxide, and increasing the gluta-
thione concentration in blood [31]. In humans, few scien-
tific data are available in relation to the use of VC, in
particular in regards to smoking cessation. To our knowl-
edge, the only study of VC in relation to smoking cessa-
tion was performed at a clinic within the Thanyarak
Institute, Pathumthani, Thailand. It included a 14-day VC
tea supplementation program in which patients were fol-
lowed for 12 weeks. Results showed a higher continuous
abstinence rate (28.1%) compared to the control group
(21.9%) [32]. However, they investigator did not evaluate
the anti-oxidant or anti-inflammatory activities in smok-
ers. Thus, the aim of this present study was to evaluate
the efficacy of both exercise and VC supplementation
alone and in combination with regards to smoking rate
and blood anti-oxidant status, oxidative stress, β-end lev-
els, over a two month period.
Methods
Subjects and Physical Characteristics
All volunteers participated in this study after giving their
written consent. The protocol was in accordance with the
1964 Declaration of Helsinki for research on human sub-
jects and was approved by the Ethics Committee at the
Faculty of Associated Medical Sciences, Chiang Mai Uni-
versity, Thailand. A baseline complete blood count (CBC)
was analyzed by the central laboratory at the Faculty of
Associated Medical Sciences, Chiang Mai University,
Thailand.
This sample included 120 Thai smoking volunteers who
w e r e  a d d i c t e d  t o  n i c o t i n e  i n  m o d e r a t e  t o  h i g h  l e v e l s ,
according to the Fagerstrom Test for Nicotine Depen-
dence; (FTND) [33]. Characteristics of participants are
provided in Table 1. Participants were randomized
divided into four groups; group 1 (n = 30): VC supple-
mentation; group 2: exercise with VC supplementation (n
= 30); group 3: exercise only (n = 30); and group 4: usual
care control--no change to normal routine (n = 30), using
a block randomized allocation system. Oxidative stress
status [malondialdehyde (MDA), nitric oxide (NOx), pro-
tein hydroperoxide (PrOOH), total antioxidant capacity
(TAC)], and β-end concentration was determined in
blood samples collected in a rested state before, after the
two month intervention. Additionally, the smoking rate
(cigarettes/day) was recorded.
Vernonia cinerea Less. Preparation
Naturally grown,raw VC was collected from local clean
area which uses natural growth without spray of insect-
toxin drugs at Chiang Mai Province, Thailand. VC was
washed four times and cut to small piece approximately
one inch and heated until dry by an oven at 70 decree C.
VC was then kept in a sterile bottle which contained a
small bag of anti-moisture silica-gel pills. Each day for
preparation, 20 grams of dry VC material and 3 cups of
clean water (390 milliliter) was boiled in a traditional potLeelarungrayub et al. Journal of the International Society of Sports Nutrition 2010, 7:21
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until water evaporated to 1 cup (130 milliliter). Con-
densed VC juice was then preserved in a clean bottle and
was provided to subjects to drink prior to smoking each,
three days per weeks for two months.
Exercise program
The exercise program was performed on treadmill at the
local community center, short warm up was performed
by stretching the upper and lower limbs for approxi-
mately 3. The actual exercise consisted of 30 min of run-
ning with a progressive incline and speed program, with a
maximum intensity of 85% of maximal heart rate (calcu-
lated manually by a trainer). The Rate of Perceived Exer-
tion (RPE) was limited to under 15 or hard exertion (6-20
Borg Scale) [34]. Our objective was to endure that partic-
ipants were performing strenuous exercise. The session
concluded with 3 min of slow speed walking. Each exer-
cise session was monitored by research personnel or a vil-
lage health volunteer.
Malondialdehyde assay
The protocol for MDA was modified from the Leelarung-
rayub's protocol [35]. 250 μl of plasma was mixed with
750 μl of ortho-phosphoric acid (2.5%, v:v) and vortexed.
Then, 500 μl of TBA (0.2 mol/L) in Tris solution (0.14
mol/L) was added. After incubation in a water bath
(90°C) for 30 min, all samples were cooled and centri-
fuged at 10,000 rpm for 3 min. A clear pink color of
supernatant was read with a spectrophotometer at 532
nm. The yield of MDA in the sample was calculated by
comparing with the absorbance of standard Tetrame-
thoxypropane (TMP) (Sigma) (0-50 μmol/L).
Nitrite assay
P l a s m a  n i t r i t e  w a s  e v a l u a t e d  a s  a n  i n d i r e c t  m a r k e r  o f
NOx, using Griess reagent following Promega's Instruc-
tions for use of the Griess reagent system [36]. First, 200
μl of plasma were mixed with 500 μl of 0.1% of N-1-
napthylethylenediamine dihydrochloride (NED) in water
and left in the dark for 5 min, then 500 μl of 1% sulfanil-
amide were added to 5% phosphoric acid and kept in the
dark again for 5 min. A slightly pink color was produced
with an absorbance reading at 520 nm. Nitrite in plasma
was calculated by comparing with the absorbance of stan-
dard sodium nitrite (NaNO3) (0-40 μmol/L).
Protein hydroperoxide assay
The protocol for PrOOH was modified from that of Gay
et al (2003) [37]. Plasma protein at 200 μl was precipi-
tated with 0.5 mol/L perchloric acid (PCA) and resolved
with 700 μl of guanidine hydrochloride (GuHCL) (6 mol/
L). Then, 40 μl of 0.2 mol/L of perchloric acid, 25 μl of
xylenol orange (5 mmol/L), and 10 μl of ferrous solution
(5 mmol/L) were added. The whole mixture was left in
the dark for 30 min before being centrifuged at 10,000
rpm for 3 min. The yellow supernatant was read for
absorbance at 560 nm. The level of PrOOH was calcu-
lated by comparing with the standard tert-butyl
hydroperoxide (0-10 μmol/L).
Total antioxidant capacity assay
Total antioxidant capacity of fresh plasma was assayed
with ABTs cation radical decolorization [38]. Stock ABTs
cation radical was produced by mixing ABTS (14 mmol/
L) and potassium persulfate (14 mmol/L) together and
leaving in the dark overnight. Working ABTs cation radi-
cal was diluted from stock ABTs with deinoized water,
until absorbance at 734 nm was shown at 0.7 ± 0.02
before adding plasma. The 10 μl of plasma was added to
990 μl of working solution ABTs cation radical in a plastic
cuvette (size 1.5 ml), and gently shaken 9 times before
adding again in the spectrophotometer. Decreased absor-
bance was recorded continuously every 1 min for 3 min-
utes, and finally calculated to ΔA/min. Total antioxidant
capacity (TAC) of plasma was calculated by comparing
with the ΔA/min of standard Trolox (0-10 mmol/L) at
0.1.
Table 1: Characteristic of all smokers in four groups.
Control
(n = 28)
VC
(n = 30)
Exercise plus VC
(n = 28)
Exercise
(n = 26)
Aged (years) 49.9 ± 9.02
(30-65)
56.1 ± 15.42
(28-82)
46.1 ± 11.35
(28-73)
49.1 ± 15.9
(28-87)
BMI (kg.m-2) 21.05 ± 1.56
(19.45 - 24.45)
22.07 ± 1.53
(18.55-25.71)
23.45 ± 2.23
(20.45-25.25)
22.24 ± 1.37
(20.08-25.71)
Smoking rate (cigarette/day)
5-10 cigarettes 18 21 13 12
11-20 cigarettes 10 9 15 14
Nicotine score 7.09 ± 1.15
(5-9)
7.17 ± 1.76
(5-10)
7.56 ± 1.02
(5-10)
7.00 ± 1.88
(5-10)Leelarungrayub et al. Journal of the International Society of Sports Nutrition 2010, 7:21
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Beta-endorphin assay
The protocol for evaluation of β-end in plasma was per-
formed according to the guidelines in β-end ELISA kit
(Catalog Number EDRF .96, MD Biosciences, Inc. USA).
500 μl of plasma was acidified with 500 μl of 1% trifluoro-
acetic acid (TFA) and mixed, then centrifuged at 10,000 ×
g for 20 min at 4degrees C. We then equilibrated a SEP-
Column (200 mg of C18) by washing with 60% acetoni-
trite in 1% TFA (1,000 μl) followed 3 times with 1% triflu-
oroacetic acid (3000 μl). We loaded the acidified plasma
solution onto the pre-treated C-18 SEP- Column, slowly
washed the column with 1% trifluoroacetic acid and col-
lected eluant. We evaporated the eluant to dryness in a
centrifugal concentrator and collected this in a polypro-
pylene tube and kept he dried sample at -20 degress C. In
the ELISA system, the dried sample was reconstituted
with assay buffer and a 50 μl of sample, 25 μl of primary
anti-serum, and 25 μl of biotinlyated β-end was loaded
into each wells. After incubation for 2 hr at room temper-
ature, wells were washed washed three times, and dried.
We then added 100 μl of diluted SA-HRP solution in each
well, except for the blank, and incubated for 1 hr at room
temperature. The plate was washed again three times and
dried. Finally, we added 100 μl of TMB solution to each
well, and incubated for 1 hr at room temperature. The
reaction was stopped with 2N HCL and absorbance read
at 450 nm. The concentration of β-end was calculated
with the standard curve of standard β-end (0.01-1,000 ng/
mL).
Measurement of end-expiratory CO level
For a measure of exhaled carbon monoxide (CO), CO was
evaluated with a MicroCO (MC02, Micro Medical Lim-
ited, UK). All smokers were standing during test. Subjects
were instructed to, hold inspired air for 10-15 seconds,
and then expire slowly until evacuating the end-expira-
tory air. Three repetitive measurements were performed
confirm values, and we recorded the maximal level of CO
(ppm).
Statistic analysis
All parameters are reported as the mean (SD). A multiple
variables repeated measurement with a Linear model
analysis (4 groups × 2 time) was used for statistical analy-
sis. The significance was set at p = 0.05.
Results
Participant characteristics for those subjects completed
all phases of the study are presented in Table 1 and are as
follows: group 1, VC supplementation (n = 30) (mean
aged = 56.1 ± 15.42 years); group 2, exercise with VC sup-
plementation (n = 28) (mean aged = 46.1 ± 11.35 years);
group 3, exercise only (n = 26) (mean aged = 49.1 ± 15.9
years); and group 4, a control (n = 28) (mean aged = 49.9
± 9.02 years). For all smokers, the baseline CBC results
showed values within normal range (7.56 ± 1.78 x103
cc.mm in WBC, 14.2 ± 2.34 g/dl in Hb, 45.68 ± 2.43% in
Hct, 233.56 ± 58.32 × 105 in Plt, 55.31 ± 5.94% in Neutro-
phil, 32.50 ± 10.14% in lymphocyte, 2.56 ± 3.16% in
monocyte, and 0.76 ± 0.62% in basophil respectively).
Mean BMI of all groups were within the normal criteria
of normal levels (18.5-24.9 kg m-2) according to the
ACSM'Health-related physical fitness assessment manual
[39]. Basic data showed that the smoking rate (cigarettes
per day) was 5-10 (n = 21) and 11-20 (n = 9) in group 1, 5-
10 (n = 13) and 11-20 (n = 15) in group 2, 5-10 (n = 12)
and 11-20 (n = 14) in group 3, and 5-10 (n = 18) and 11-20
(n = 10) in group 4 (Table 1).
Smoking rate (cigarettes per day)
In this study, the cigarettes were divided into two types,
light and self-rolled. In Figure 1, the yields of light and
self-rolled cigarettes at the pre-intervention period were
(5.93 ± 3.21 via 1.23 ± 2.01) in group 1, (8.68 ± 5.21 via
0.35 ± 2.34) in group 2, (7.46 ± 6.23 via 0.78 ± 1.11) in
group 3, and (6.34 ± 2.20 via 0.98 ± 1.23) in group 4. After
2 months of intervention, results showed that the yield of
cigarettes per day had reduced significantly to lower than
that at the pre-intervention period in all groups, excepted
group 4. The findings were 2.45 ± 4.67 (p < 0.05) via 0.56
± 2.34 (p < 0.01) for group 1, 3.23 ± 4.32 (p < 0.01) via 0.21
± 1.23 (p < 0.05) for group 2, 3.45 ± 2.21, (p < 0.01) via
0.45 ± 2.89, (p < 0.05) for group 3, and 7.23 ± 2.34 via 0.89
± 1.34 for group 4 (p > 0.05). When calculating the per-
centage of cigarette reduction per day for both light and
self-rolled types, it was reduced in all groups, excepted
for group 4. Reduction values of (59.52%, and 54.47%) for
group 1, (62.79%, and 40.00%) for group 2, (53.75%, and
42.30%) for group 3. A 14.04% increase (light) 9.2% reduc-
tion (self-rolled) was noted for group 4.
Oxidative Stress Biomarkers
At the pre-intervention assessment, MDA and PrOOH
were not difference between groups (Figure 2). The MDA
levels of all groups had no significant difference, i.e.
group 4 (2.34 ± 0.023 μmol/L), group 1 (2.45 ± 0.018
μmol/L), group 2 (2.32 ± 0.012 μmol/L), and group 3 (2.41
± 0.023 μmol/L). After the two month intervention, the
results showed a significant decrease in MDA for group 1
(1.89 ± 0.023 μmol/L, p < 0.01), and a slight non-signifi-
cant decrease in group 2 (2.28 ± 0.034 μmol/L), whereas,
a significant increase occurred in group 3 (2.95 ± 0.02
μmol/L, p < 0.05), and a slight increase in group 4 (2.45 ±
0.034 μmol/L)
As for PROOH, group 4 showed unchanged PrOOH
levels (from 2.34 ± 1.11 to 2.32 ± 0.98 μmol/L), whereas,
group 3 showed slightly increased levels (from 2.31 ± 0.01
to 2.51 ± 0.22 μmol/L). The levels of PrOOH decreased inLeelarungrayub et al. Journal of the International Society of Sports Nutrition 2010, 7:21
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group 1 (2.35 ± 0.67 to 1.76 ± 0.23 μmol/L) and group 2
(2.21 ± 0.04 to 1.98 ± 0.03 μmol/L) during the two month
intervention period (p > 0.05).
For nitrite (Figure 3, left), a significant decrease was
shown in group 1 (22.23 ± 1.78 μmol/L), compared to
pre-intervention (24.23 ± 2.12 μmol/L). However, group 3
showed a significant increase (32.34 ± 2.78 μmol/L) com-
pared to pre-intervention (25.23 ± 1.30 μmol/L), as did
group 2, but at a lower level (31.23 ± 2.12 μmol/L), com-
pared to pre-intervention (28.23 ± 1.45 μmol/L). On the
other hand, group 4 showed no significant change (24.87
± 1.28 and 25.23 ± 1.11 μmol/L) (p > 0.05).
In the TAC status (Figure 3, right), in all groups after
two months intervention, the levels of TAC improved sig-
nificantly in group 1 (2.12 ± 0.012 mmol/L), group 2 (1.45
± 0.034 mmol/L), and group 3 (1.23 ± 0.012 mmol/L),
compared to pre-interventine (0.99 ± 0.012, 0.87 ± 0.013,
0.91 ± 0.011 mmol/L, respectively), but they did not
change in group 4 (0.93 ± 0.023 and 0.98 ± 0.031 mmol
Trolox/L) (p > 0.05).
Exhaled CO and β-Endorphin levels
This study found that the exhaled CO level (Figure 4) sig-
nificantly decreased in group 1 (5.40 ± 2.99 ppm, p <
0.01), group 2 (4.98 ± 1.22 ppm, p < 0.01), and group 3
(4.96 ± 2.15 ppm, p < 0.01), compared to pre-intervention
(10.66 ± 1.45, 11.93 ± 1.87, 10.46 ± 1.33 ppm), whereas,
group 4 showed a slight increase (8.67 ± 1.11 and 9.75 ±
1.28 ppm). For β-end concentration (Figure 5), group 2
(198.00 ± 4.23 pg/ml) and group 3 (201.00 ± 2.31 pg/ml)
improved significantly compared to base line (92.45 ±
2.12 and 99.50 ± 3.23 pg/ml) (p < 0.001), whereas, reduc-
tion was significant in group 1 (65.23 ± 5.23 pg/ml) com-
pared to base line (80.23 ± 2.45 pg/ml) (p < 0.05). There
was no change in group 4 between baseline (82.34 ± 2.34
pg/ml) and after the two month intervention (79.23 ±
2.12 pg/ml).
Discussion
From these results, it can be concluded that VC supple-
mentation in a small group of smokers can reduce oxida-
tive stress and the rate of cigarette smoking per day, but
VC had no effect on the β-end level. Exercise was chosen
for changing behavior to smoking cessation and
improved β-end level, but our heavy intensity of exercise
actually increased oxidative stress. It is possible that a
lower intensity exercise program may be best in this
Figure 1 Cigarette yields per day of light (right) and self-rolling (left) types between pre- and post-intervention periods in each groups, 
control, VC, exercise with VC, and exercise. Each point represents the mean of cigarette yield per day. The percentage at post-intervention was 
compared to the pre-intervention.Leelarungrayub et al. Journal of the International Society of Sports Nutrition 2010, 7:21
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regard, unless the exercise is combined with supplemen-
tation such as VC. The combination of VC supplementa-
tion and exercise helped to reduce the rate of smoking
when compared to a control group, especially in smokers
using light cigarettes, whereas the combined intervention
also improved both β-end levels and antioxidant status as
measured by TAC
Vernonia Cincerea and smoking cessation
From this preliminary study, we note very interesting
results of the co-intervention between the natural plant,
VC and strenuous exercise, in relation to smoking rate in
a local northern area, Chiang Mai province, Thailand,
which may have application to her parts of South-East
Asia or Hawaii [25-27]. Previous study in a short 14 day
clinical trial at Thanyarak Institue, Pathumthani in Thai-
land [32] found a higher continuous abstinence rate
(28.1%) in a VC supplemented group, compared to a con-
trol group of smokers (21.9%). However, the design of the
study was difference from ours, with regards to the prep-
aration of the VC juice, as well as the intake of the juice.
In the present study, our subjects were asked to drink the
VC juice prior to each time they planned on smoking.
They were instructed to keep the condensed VC juice in
the mouth for 1-2 seconds prior to being swallowed.
In our initial experiences with VC, all smokers had
adverse events with tongue bitter or numbness (100%),
with a few having nausea (10.5%), and headache (5.2%);
however, this ceased after the initial week of treatment.
Whereas in the study of Wongwiwaathananukit and co-
worker [32], subjects reported more adverse events such
as tongue numbness (46.9%), upper abdominal pain
(21.9%), nausea (28.1%), headache (40.6), palpitation
(15.6%), drowsiness (59.4%), craving reduction (59.4%),
and dislike for the taste and smell of cigarette smoke
(62.5%) after 14 days of VC supplementation.
Baseline of Oxidative Stress
This study showed relative high oxidative stress values in
all smokers at the pre-intervention period. Previous study
by Bloomer and colleagues [40] in young smokers (24 ± 4
years) showed lower MDA (0.919 ± 0.32 μmol/L) than
our study (more than 2.0 μmol/L), which included middle
to older aged subjects (46.1 ± 9.02 years in control, 56.7 ±
15.42 years in VC, 46.2 ± 11.35 years in exercise with VC,
and 49.5 ± 15.9 year in exercise).However, the TAC levels
appeared similar.
For NOx with nitrite levels in all smokers; 25.23 ± 1.11
in control, 24.23 ± 2.12 μmol/L in VC, 28.23 ± 1.45 μmol/
L in exercise with VC, and 25.23 ± 1.30 μmol/L in exer-
Figure 2 The levels of MDA (left) and protein hydroperoxide (PrOOH) (right) between pre- and post-intervention periods in each group, 
control, VC, exercise with VC, and exercise only. Each point represented the mean and standard deviation and significant level at p < 0.05 (#) and 
p < 0.01 (##).Leelarungrayub et al. Journal of the International Society of Sports Nutrition 2010, 7:21
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Figure 3 The levels of nitrite (left) and Total antioxidant capacity (TAC) (right) between pre- and post-intervention periods in each group, 
control, VC, exercise with VC, and exercise only. Each point represented the mean and standard deviation and significant level at p < 0.05 (#) and 
p < 0.01 (##).
Figure 4 The exhale carbon monoxide (CO) between pre- 
(oblique line) and post-(no line) intervention periods in each 
group, control, VC, exercise with VC, and exercise only. Each bar 
represented the mean and standard deviation, and significant level at 
p < 0.05 (#).
Figure 5 The beta-endorphin levels between pre- (oblique line) 
and post-(no line) intervention periods in each group, control, 
VC, exercise with VC, and exercise only. Each bar represented the 
mean and standard deviation, and significant level at p < 0.05 (#) and 
p < 0.001 (# #).Leelarungrayub et al. Journal of the International Society of Sports Nutrition 2010, 7:21
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cise (Figure 3 left). Previous study in healthy, sedentary,
younger (22.5 ± 3.45 years) or older individuals (65.7 ±
6.14 years) noted mean levels lower levels which were
slightly lower but similar to our values (23.78 ± 5.72
μmol/L and 22.17 ± 6.14 μmol/L) [41]. The higher nitrite
levels in our study may be related to the high level of
PrOOH (Figure 2 right). Many reports show that NOx
can react and damage protein. For example, Ischiopoulos
and al-Mehdi [42] showed that peroxynitrite was gener-
ated by the reaction of NOx with superoxide and has a
direct effect on tryptophan and cysteine, including pro-
tein fragmentation. Previous study in smokers showes the
high level of oxidized protein compared to nonsmokers
[43].
Intervention: Oxidative Stress
Oxidative stress values changes with the intervention in
all groups except for group 4. In Group 1, MDA, PrOOH,
and NOx significantly decreased, whereas TAC
increased. In Group 2, MDA and PrOOH decreased, with
no other changes noted. In Group 3, MDA, PrOOH,
NOx, TAC, and beta-endorphin levels all increased sig-
nificantly
Figure 3 shows the plasma NOx levels after the 2 month
intervention, and results showed an improved NOx level
in group 3 (32.34 ± 2.78 μmol/L) and a slightly increased
level in group 2 (1.23 ± 2.12 μmol/L), but it was lower
than in a previous study by Franco [41], which showed
higher levels of NOx in both healthy younger (44.73 ±
6.48 μmol/L) and older subjects (45.88 ± 9.84 μmol/L).
Physiologically, a lower level of NOx can be indicative of a
depressed function in nitric oxide synthase (NOS) and
lower release of NOx in the smoker's plasma, which can
cause hypertension or stroke in the long term [44]. Fortu-
nately, results in our study showed an increasing level of
NOx in group 2 and 3, which might aid overall cardiovas-
cular health. We also noted improvement of TAC (statis-
tically) in all groups, excepted group 4 (VC > exercise and
VC > exercise, alone). A previous study showed the anti-
oxidant activity of VC flowers in arthritis-induced rats
[31], which corresponded to a reduction in lipid peroxide
in the liver, plasma and spleen, and also an increase in
glutathione in the blood.
Intervention: β-endorphin and CO
Although this study was carried out in a small group of
smokers, the results related to β-end showed a significant
increase after strenuous exercise (Figure 5). The β-end
level in this study was nearly the same as the mean value
(79.46 ± 6.31 pg/ml) of a previous study [45] of smokers
who consumed less than 10 cigarettes per day. In all the
smokers of our study, the mean number of cigarettes
smoked per day was less than 10; group 4 (6.34 ± 2.20),
group 1 (5.93 ± 3.21), group 2 (8.68 ± 5.21), and group 3
(7.46 ± 6.23). The β-end levels were 82.34 ± 2.34 pg/ml
(group 4), 80.23 ± 2.45 pg/ml (group 1), 92.45 ± 2.12 pg/
ml (group 2), and 99.50 ± 3.23 pg/ml (group 3). After the
2 month intervention, only group 2 (198.00 ± 4.23 pg/ml)
and 3 (201.00 ± 2.31 pg/ml) showed a significant increase
in β-endorphin levels. It should be noted that in group 1,
the slight reduction of β-end level was significant (p <
0.05), thus suggesting that the increased β-end in group 2
and 3 most likely resulted from exercise only and not
from VC. From previous reports, the intensity and type of
exercise for increasing β-end is still unclear, but resis-
tance and moderate intensity exercise did not influence
β-endorphin level [46].
There has been little evidence to support a specific
exercise program for smoking cessation or for reducing
the rate of smoking. A previous study of 10 women smok-
ers (27 ± 11 cigarettes per day and 29 ± 15 ppm of exhaled
CO) by Marcus and co-worker [23] showed that a smok-
ing cessation program, plus exercise via cycle ergometery
at 70-85% intensity for three supervised sessions per
week for 15 weeks, resulted in 30% smoking abstinence at
the end of treatment. However, in our study, the rate of
cigarette consumption was lower than 10 cigarettes per
day, with lower CO (Figure 4). Thus, the reduction rate
was higher for light smoking (62.79% in group 2, 59.52%
in group 1, 53.75% in group 3) than self-rolled cigarettes
(54.47% in group 1, 42.30% in group 3, 40.0% in group 2)
(Figure 1).
VC and Exercise for smoking cessation
Vigorous exercise has been used to assist in smoking ces-
sation, as this results in increased caloric expenditure
[47], which may offset the often observed weight gain
associated with cessation and can also serve as a substi-
tute behavior during cessation trials [48]. Exercise may be
associated with positive, mood changes [49], which aid in
decreasing both physiological [50] and psychological [51]
conditions and is recommended for long-term sucess in
smoking cessation [52].
The active compounds in VC have been rarely studied,
in human subjects in particular. It is therefore noteworthy
that the flower of VC extract contains refluxing 80% etha-
nol, active compounds composed of various substances
as steroids, saponins, alkaloids, carbohydrates, fla-
vonoids, phenols, tanins, and proteins [31]. Currently, the
work of Misra and co-worker [53] shows that extracts of
the VC leaf include chloroform, methanol, and petroleum
ether, which have analgesic, antipyretic, and anti-inflam-
matory activities in a rat model. It has been suggested
that VC decreases locomotory, exploratory behavior and
increases the body scratching behavioral model that is
probably due to CNS depression with excitatory activities
of the monoamines neurotransmitters [54,55]. However,
there is no evidence supporting this hypothesis in regardsLeelarungrayub et al. Journal of the International Society of Sports Nutrition 2010, 7:21
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to smoking behavior. In our study, the active compounds
in VC juice were not analyzed; hence, we cannot state
with confidence the chief actives responsible for teh
reduction in smoking rate. Plans for further analysis of
VC in future experimentals should be made.
Conclusion
This is a preliminary study of the influence of VC supple-
mentation and exercise on oxidative stress and β-end
release, with relevance to smoking cessation. Results indi-
cate the use of VC supplementation for reducing smoking
rate,with and with our exercise. The reduction in smok-
ing rate may be associated with levels of oxidative stress.
Both VC supplementation and exercise may compensate
for nicotine addiction. Additional studies using larger
samples, as well as a combination of both men and
women who are heavy smokers are needed to extend
these findings.
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